Oricell Therapeutics has now raised over $100 million in its final funding round before the Chinese CAR-T therapy biotech seeks to go public.
Morbi et tellus imperdiet, aliquam nulla sed, dapibus erat. Aenean dapibus sem non purus venenatis vulputate. Donec accumsan eleifend blandit. Nullam auctor ligula
Oricell Therapeutics has now raised over $100 million in its final funding round before the Chinese CAR-T therapy biotech seeks to go public.